GM-CSF drives immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12
H.-J. Paust, N. Song, D. DeFeo, N. Asada, S. Tuzlak, Y. Zhao, J.-H. Riedel, M. Hellmig, A. Sivayoganathan, A. Peters, A. Kaffke, A. Borchers, U. O. Wenzel, O. M. S. M. Steinmetz, G. Tiegs, , U. P. Panzer
The paper identifies GM-CSF-producing T cells that drive glomerulonephritis by licensing monocyte-derived cells to produce MMP12, leading to renal tissue damage.
bioRxiv · Jun 13, 2022Immunology